Waneta Tuttle, PhD
Tramway Venture Partners
Waneta has 40 years of experience at the intersection of technology and health care. An entrepreneur, executive and experienced board member she brings an innovative spirit, grounded in practical understanding of health care. She holds a Ph.D. and an MBA and has started six companies. She served on the Board of Directors for NASDAQ traded MGI Pharma through its sale to Eisai Pharmaceuticals and she served for ten years (2007-2017) on the Board of Health Care Service Corporation, the nation’s fourth largest health insurer by enrollment. HCSC operates Blue Cross and Blue Shield of Illinois, Montana, New Mexico, Oklahoma and Texas. She also serves as a member of the Advisory Board to Tullis Health Investors of Florida and is a member of the corporation for the Charles Stark Draper Laboratory in Cambridge, Massachusetts.